BEAM
NASDAQStockBeam Therapeutics Inc.
$25.40-0.69 (-2.65%)
52-Week Range
$14.54
$35.41
Key Stats
Market Cap
2.6B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.17
Volume
1.9M
Avg Volume
2.0M
Performance
1M
-5.05%
3M
-6.47%
6M
+20.25%
YTD
-5.71%
1Y
-6.67%
3Y
-24.20%
5Y
-73.01%
Price Chart
ETF Exposure
BEAM is held by 96 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| TYNE | Direxion Nanotechnology ETF | 11.13% |
| ARKG | ARK Genomic Revolution ETF | 5.02% |
| ARKK | ARK Innovation ETF | 3.46% |
| NIFE | Direxion Fallen Knives ETF | 3.21% |
| GNOM | Global X - Genomics & Biotechnology ETF | 2.24% |
| WDNA | WisdomTree BioRevolution Fund | 1.91% |
| MEDX | Horizon Kinetics Medical ETF | 1.23% |
| XBI | State Street SPDR S&P Biotech ETF | 0.97% |
| HELX | Franklin Genomic Advancements ETF | 0.85% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.71% |
| JSML | Janus Henderson Small Cap Growth Alpha ETF | 0.47% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.33% |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.24% |
| PWS | Pacer WealthShield ETF | 0.23% |
| IBB | iShares Biotechnology ETF | 0.21% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.20% |
| IWO | iShares Russell 2000 Growth ETF | 0.20% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.19% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.17% |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.16% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.15% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.14% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.14% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.13% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.12% |
| BKSE | BNY Mellon US Small Cap Core Equity ETF | 0.12% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.12% |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.11% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.10% |
| RSSL | Global X - Russell 2000 ETF | 0.09% |
| VTWO | Vanguard Russell 2000 ETF | 0.09% |
| IWM | iShares Russell 2000 ETF | 0.08% |
| VBK | Vanguard Small-Cap Growth ETF | 0.08% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.08% |
| TMSL | T. Rowe Price Small-Mid Cap ETF | 0.07% |
| GINN | Goldman Sachs Innovate Equity ETF | 0.07% |
| JHMH | John Hancock Multifactor Health Care ETF | 0.07% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.06% |
| UWM | ProShares - Ultra Russell2000 | 0.06% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.05% |
| URTY | ProShares - UltraPro Russell2000 | 0.05% |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.05% |
| DXUV | Dimensional - US Vector Equity ETF | 0.04% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.04% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.04% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.04% |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.04% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.04% |
| JKL | iShares Morningstar Small-Cap Value ETF | 0.04% |
| VHT | Vanguard Health Care ETF | 0.04% |
Page 1 of 2Next
About BEAM ETF Exposure
Beam Therapeutics Inc. (BEAM) is held by 96 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.6B, BEAM is a widely held institutional stock. The stock currently trades at $25.40. Investors can gain exposure to BEAM through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BEAM, sorted by portfolio weight.